These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Norplant may be too costly for low income women.
    Journal: Family Plan World; 1991; ():7, 14. PubMed ID: 12346943.
    Abstract:
    Norplant was developed by the Population Council in 1980, approved by the USFDA in December 1990, and has been marketed in the US since February 1991. The US was the 17th country to give regulatory approval to the contraceptive delivery system. Norplant has been used by more than 700,000 women worldwide and is currently used by more than 15,000 women in the US. The high up-front cost of this new method of contraception, however, keeps many women, such as poor women and teenagers, from using Norplant. The $800-1000 total cost of Norplant over a five-year period makes contraception with Norplant less expensive than use of the birth control pill, but many American women simply cannot conveniently amass the $800-1000 needed at the beginning of the five-year period for the purchase and insertion of Norplant. Removal of the Norplant rods is an added expense. There are, however, signs that Norplant may be made more accessible to low-income women in the US. The planned production and marketing of a two-rod version of Norplant should lower the price and make removal easier. Furthermore, Medicaid has recently decided to partially reimburse Norplant users in some states, and insurance companies have recently begun to reimburse their clients for Norplant. Wyeth-Ayerst, manufacturers of Norplant, recently announced that a foundation will be established to help low-income women pay for the contraceptive.
    [Abstract] [Full Text] [Related] [New Search]